These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

208 related articles for article (PubMed ID: 29936422)

  • 1. Closing the Loop on Managing Youth With Type 1 Diabetes: Children Are Not Just Small Adults.
    Sherr JL
    Diabetes Care; 2018 Aug; 41(8):1572-1578. PubMed ID: 29936422
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A Technological Revolution: The Integration of New Treatments to Manage Type 1 Diabetes.
    Galderisi A; Sherr JL
    Pediatr Ann; 2019 Aug; 48(8):e311-e318. PubMed ID: 31426099
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Do-It-Yourself Artificial Pancreas Systems: A Review of the Emerging Evidence and Insights for Healthcare Professionals.
    Jennings P; Hussain S
    J Diabetes Sci Technol; 2020 Sep; 14(5):868-877. PubMed ID: 31847570
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Six Months of Hybrid Closed-Loop Versus Manual Insulin Delivery With Fingerprick Blood Glucose Monitoring in Adults With Type 1 Diabetes: A Randomized, Controlled Trial.
    McAuley SA; Lee MH; Paldus B; Vogrin S; de Bock MI; Abraham MB; Bach LA; Burt MG; Cohen ND; Colman PG; Davis EA; Hendrieckx C; Holmes-Walker DJ; Kaye J; Keech AC; Kumareswaran K; MacIsaac RJ; McCallum RW; Sims CM; Speight J; Stranks SN; Sundararajan V; Trawley S; Ward GM; Jenkins AJ; Jones TW; O'Neal DN;
    Diabetes Care; 2020 Dec; 43(12):3024-3033. PubMed ID: 33055139
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Closing the Loop in Adults, Children and Adolescents With Suboptimally Controlled Type 1 Diabetes Under Free Living Conditions: A Psychosocial Substudy.
    Barnard KD; Wysocki T; Ully V; Mader JK; Pieber TR; Thabit H; Tauschmann M; Leelarathna L; Hartnell S; Acerini CL; Wilinska ME; Dellweg S; Benesch C; Arnolds S; Holzer M; Kojzar H; Campbell F; Yong J; Pichierri J; Hindmarsh P; Heinemann L; Evans ML; Hovorka R
    J Diabetes Sci Technol; 2017 Nov; 11(6):1080-1088. PubMed ID: 28367636
    [TBL] [Abstract][Full Text] [Related]  

  • 6. One-year experience of hybrid closed-loop system in children and adolescents with type 1 diabetes previously treated with multiple daily injections: drivers to successful outcomes.
    Petrovski G; Al Khalaf F; Campbell J; Umer F; Almajaly D; Hamdan M; Hussain K
    Acta Diabetol; 2021 Feb; 58(2):207-213. PubMed ID: 33044604
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Closed-loop artificial pancreas using subcutaneous glucose sensing and insulin delivery and a model predictive control algorithm: preliminary studies in Padova and Montpellier.
    Bruttomesso D; Farret A; Costa S; Marescotti MC; Vettore M; Avogaro A; Tiengo A; Dalla Man C; Place J; Facchinetti A; Guerra S; Magni L; De Nicolao G; Cobelli C; Renard E; Maran A
    J Diabetes Sci Technol; 2009 Sep; 3(5):1014-21. PubMed ID: 20144414
    [TBL] [Abstract][Full Text] [Related]  

  • 8. New closed-loop insulin systems.
    Boughton CK; Hovorka R
    Diabetologia; 2021 May; 64(5):1007-1015. PubMed ID: 33550442
    [TBL] [Abstract][Full Text] [Related]  

  • 9. 10-Day structured initiation protocol from multiple daily injection to hybrid closed-loop system in children and adolescents with type 1 diabetes.
    Petrovski G; Al Khalaf F; Campbell J; Fisher H; Umer F; Hussain K
    Acta Diabetol; 2020 Jun; 57(6):681-687. PubMed ID: 31953687
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Closed-loop artificial pancreas using subcutaneous glucose sensing and insulin delivery and a model predictive control algorithm: the Virginia experience.
    Clarke WL; Anderson S; Breton M; Patek S; Kashmer L; Kovatchev B
    J Diabetes Sci Technol; 2009 Sep; 3(5):1031-8. PubMed ID: 20144416
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Safety and Performance of the Omnipod Hybrid Closed-Loop System in Adults, Adolescents, and Children with Type 1 Diabetes Over 5 Days Under Free-Living Conditions.
    Sherr JL; Buckingham BA; Forlenza GP; Galderisi A; Ekhlaspour L; Wadwa RP; Carria L; Hsu L; Berget C; Peyser TA; Lee JB; O'Connor J; Dumais B; Huyett LM; Layne JE; Ly TT
    Diabetes Technol Ther; 2020 Mar; 22(3):174-184. PubMed ID: 31596130
    [No Abstract]   [Full Text] [Related]  

  • 12. Type 1 diabetes mellitus management in young children: implementation of current technologies.
    Nevo-Shenker M; Phillip M; Nimri R; Shalitin S
    Pediatr Res; 2020 Mar; 87(4):624-629. PubMed ID: 31715623
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Characterizing Glycemic Control and Sleep in Adults with Long-Standing Type 1 Diabetes and Hypoglycemia Unawareness Initiating Hybrid Closed Loop Insulin Delivery.
    Malone SK; Peleckis AJ; Grunin L; Yu G; Jang S; Weimer J; Lee I; Rickels MR; Goel N
    J Diabetes Res; 2021; 2021():6611064. PubMed ID: 33628834
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Young Children Have Higher Variability of Insulin Requirements: Observations During Hybrid Closed-Loop Insulin Delivery.
    Dovc K; Boughton C; Tauschmann M; Thabit H; Bally L; Allen JM; Acerini CL; Arnolds S; de Beaufort C; Bergenstal RM; Campbell F; Criego A; Dunger DB; Elleri D; Evans ML; Fröhlich-Reiterer E; Hofer S; Kapellen T; Leelarathna L; Pieber TR; Rami-Merhar B; Shah VN; Sibayan J; Wilinska ME; Hovorka R;
    Diabetes Care; 2019 Jul; 42(7):1344-1347. PubMed ID: 31221700
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Six months of hybrid closed loop in the real-world: An evaluation of children and young adults using the 670G system.
    Berget C; Messer LH; Vigers T; Frohnert BI; Pyle L; Wadwa RP; Driscoll KA; Forlenza GP
    Pediatr Diabetes; 2020 Mar; 21(2):310-318. PubMed ID: 31837064
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Progress of artificial pancreas devices towards clinical use: the first outpatient studies.
    Russell SJ
    Curr Opin Endocrinol Diabetes Obes; 2015 Apr; 22(2):106-11. PubMed ID: 25692927
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Using a Do-It-Yourself Artificial Pancreas: Perspectives from Patients and Diabetes Providers.
    Palmer W; Greeley SAW; Letourneau-Freiberg LR; Naylor RN
    J Diabetes Sci Technol; 2020 Sep; 14(5):860-867. PubMed ID: 32680447
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A Comparison of Two Hybrid Closed-Loop Systems in Italian Children and Adults With Type 1 Diabetes.
    Bassi M; Teliti M; Lezzi M; Iosca A; Strati MF; Carmisciano L; d'Annunzio G; Minuto N; Maggi D
    Front Endocrinol (Lausanne); 2021; 12():802419. PubMed ID: 35116007
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effect of Afrezza on Glucose Dynamics During HCL Treatment.
    Galderisi A; Cohen N; Calhoun P; Kraemer K; Breton M; Weinzimer S; Cengiz E
    Diabetes Care; 2020 Sep; 43(9):2146-2152. PubMed ID: 32661108
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Is an artificial pancreas (closed-loop system) for Type 1 diabetes effective?
    Boughton CK; Hovorka R
    Diabet Med; 2019 Mar; 36(3):279-286. PubMed ID: 30183096
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.